Factors affecting complete hypertension cure after adrenalectomy for aldosterone-producing adenoma: Outcomes in a large series

Urologia Internationalis

Volumn 90, Issue 4, 2013, Pages 430-434

  Zhang, Xiaohua ^a   Zhu, Zhaowei ^a   Xu, Tianyuan ^a   Shen, Zhoujun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Adrenal gland; Adrenalectomy; Hypertension; Primary aldosteronism

Indexed keywords

ALDOSTERONE; ANTIHYPERTENSIVE AGENT; CREATININE; POTASSIUM;

ADRENALECTOMY; ADULT; AGE DISTRIBUTION; ALDOSTERONE BLOOD LEVEL; ANTIHYPERTENSIVE THERAPY; ARTICLE; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; HYPOKALEMIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NODULAR HYPERPLASIA; OUTCOME ASSESSMENT; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TUMOR VOLUME;

EID: 84879129941     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000347028     Document Type: Article

References (21)

1. Conn JW: Primary aldosteronism: a new clinical syndrome. J Lab Clin Med 1955; 45: 3-17.
2. Douma S, Petidis K, Doumas M, Papaefthimiou P, Triantafyllou A, Kartali N, et al: Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet 2008; 371: 1921-1926.
3. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, et al: A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 2006; 48: 2293-2300.
4. Steichen O, Zinzindohoué F, Plouin PF, Amar L: Outcomes of adrenalectomy in patients with unilateral primary aldosteronism: a review. Horm Metab Res 2012; 44: 221-227.
5. Lumachi F, Ermani M, Basso SM, Armanini D, Iacobone M, Favia G: Long-term results of adrenalectomy in patients with aldosteroneproducing adenomas: multivariate analysis of factors affecting unresolved hypertension and review of the literature. Am Surg 2005; 71: 864-869.
6. Meyer A, Brabant G, Behrend M: Long-term follow-up after adrenalectomy for primary aldosteronism. World J Surg 2005; 29: 155-159.
7. Waldmann J, Maurer L, Holler J, Kann PH, Ramaswamy A, Bartsch DK, Langer P: Outcome of surgery for primary hyperaldosteronism. World J Surg 2011; 35: 2422-2427.
8. van der Linden P, Steichen O, Zinzindohoué F, Plouin PF: Blood pressure and medication changes following adrenalectomy for unilateral primary aldosteronism: a follow-up study. J Hypertens 2012; 30: 761-769.
9. Utsumi T, Kawamura K, Imamoto T, Kamiya N, Komiya A, Suzuki S, et al: High predictive accuracy of Aldosteronoma Resolution Score in Japanese patients with aldosterone-producing adenoma. Surgery 2012; 151: 437-443.
10. Zarnegar R, Young WF Jr, Lee J, Sweet MP, Kebebew E, Farley DR, et al: The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. Ann Surg 2008; 247: 511-518.
11. Giacchetti G, Ronconi V, Rilli S, Guerrieri M, Turchi F, Boscaro M: Small tumor size as favorable prognostic factor after adrenalectomy in Conn's adenoma. Eur J Endocrinol 2009; 160: 639-646.
12. Wu VC, Chueh SC, Chang HW, Lin LY, Liu KL, Lin YH, et al: Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma. Am J Kidney Dis 2009; 54: 665-673.
13. Trésallet C, Salepçioglu H, Godiris-Petit G, Hoang C, Girerd X, Menegaux F: Clinical outcome after laparoscopic adrenalectomy for primary hyperaldosteronism: the role of pathology. Surgery 2010; 148: 129-134.
14. Murashima M, Trerotola SO, Fraker DL, Han D, Townsend RR, Cohen DL: Adrenal venous sampling for primary aldosteronism and clinical outcomes after unilateral adrenalectomy: a single-center experience. J Clin Hypertens (Greenwich) 2009; 11: 316-323.
15. Kim RM, Lee J, Soh EY: Predictors of resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenoma. J Korean Med Sci 2010; 25: 1041-1044.
16. Mourad JJ, Girerd X, Milliez P, Lopez-Sublet M, Lejeune S, Safar ME: Urinary aldosteroneto-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas. Am J Hypertens 2008; 21: 742-747.
17. Rayner B: Primary aldosteronism and aldosterone-associated hypertension. J Clin Pathol 2008; 61: 825-831.
18. Rossi GP, Pessina AC: Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma. J Hypertens 2009; 27: 656-657.
19. Reincke M, Rump LC, Quinkler M, Hahner S, Diederich S, Lorenz R, et al: Risk factors associated with a low glomerular filtration rate in primary aldosteronism. J Clin Endocrinol Metab 2009; 94: 869-875.
20. Gaddam KK, Pimenta E, Husain S, Calhoun DA: Aldosterone and cardiovascular disease. Curr Probl Cardiol 2009; 34: 51-84.
21. Wang B, Zhang G, Ouyang J, Deng X, Shi T, Ma X, et al: Association of DNA polymorphisms within the CYP11B2/CYP11B1 locus and postoperative hypertension risk in the patients with aldosterone-producing adenomas. Urology 2010; 76: 1018.e1-1018.e7.